Activin A (a homodimer of two activin beta A subunits) has been shown to in
duce the neuronal differentiation of rat pheochromocytoma PC12 cells. We st
udied activin A and its receptor gene expression in human pheochromocytomas
in vivo and in vitro to clarify the potential involvement of activin A in
the pathophysiology of these tumors. We first screened 20 pheochromocytomas
and nine normal adrenal tissues for activin beta A mRNA expression. Northe
rn blots hybridized with specific oligonucleotide probes detected weak sign
als for activin beta A transcripts in pheochromocytomas. Both type I and ty
pe II activin receptor (ActR-I, ActR-IB and ActR-II) mRNA expression was al
so detectable in the pheochromocytoma tissues.
In primary cultures of pheochromocytoma cells, expression of activin beta A
mRNA was readily detectable by Northern blotting, and secretion of activin
A into the conditioned medium was confirmed by an enzyme-linked immunosorb
ent assay. The expression of activin beta A mRNA and secretion of activin A
were induced by (Bu)(2)cAMP after 1 and 3 days of treatment (all P<0.05).
A protein kinase inhibitor, staurosporine, inhibited the basal and (Bu)(2)c
AMP-induced accumulation of activin beta A mRNA (P<0.05). In addition, indu
ction of chromaffin phenotype by dexamethasone also inhibited the basal and
(Bu)(2)cAMP-induced expression of activin A at both mRNA and protein level
s (all P<0.05). In contrast, the expression of ActR-I and ActR-IB mRNAs was
not affected by these agents in cultured pheochromocytoma cells.
In summary, activin beta A subunit and activin receptors are expressed in h
uman pheochromocytomas. Production of activin A in cultured pheochromocytom
a cells is induced through the protein kinase A pathway, but reduced during
chromaffin differentiation. Therefore, activin A may function as a local n
eurotrophic factor via an auto/paracrine manner in human pheochromocytomas.